Centre National De La Recherche Scientifique

Université De Versailles—saint-quentin-en-yvelines

Korea Research Institute of Chemical Technology

Université Paris—sud

Université De Caen Basse Normandie

Patricia Horcajada-Cortes

Christian Serre

Ruxandra Gref

Gérard Ferey

Patrick Couvreur

Jong-San Chang

Young-Kyu Hwang

Laszlo Jicsinszky

Marco Daturi

Philip Leslie Llewellyn

Samia Daoud-Mahammed

Violeta Rodriguez-Ruiz

Milo Malanga

Alexandre Vimont

Valentina Agostoni

The invention relates to nanoparticles made from organometallic hybrid materials made from iron carboxylates, used for example as contrast agents. The particles can also be used for the encapsulation and vectoring of molecules of interest such as active pharmaceutical agents, cosmetically interesting compounds and markers. Apart from the intrinsic properties thereof for imaging, said nanoparticles give good results in terms of capacity of loading with medicaments and in biocompatibility.

Organic/inorganic hybrid nanoparticulates made from iron carboxylates

The present invention concerns metal-organic hybrid solids having a modified outer surface. These solids can be used, for example, for the storage and vectoring of molecules of interest such as pharmaceutically active ingredients, compounds of interest in cosmetics and markers, for example contrast agents. These solids have good results in terms of active drug loading capacities, biocompatibility, stability and controlling the release of the active ingredients encapsulated.

Organic-inorganic hybrid solid having a modified outer surface

The invention relates to nanoparticles made from organometallic hybrid materials made from iron carboxylates, used for example as contrast agents. The particles can also be used for the encapsulation and vectoring of molecules of interest such as active3 pharmaceutical agents, cosmetically interesting compounds and markers. Apart from the intrinsic properties thereof for imaging, said nanoparticles give good results in terms of capacity for loading with medicaments and in biocompatibility.

The present invention relates to reducible porous crystalline solids, constituted of a metal-organic framework (MOF), for the separation of mixtures of molecules having different unsaturation degrees and/or a different number of unsaturations with a selectivity that can be adjusted by controlling the reduction of the MOF. The MOF solids of the present invention, after reduction, have a strong affinity for molecules containing at least one unsaturation. They can be used in various separation processes, especially those relating to hydrocarbons.

Reducible porous crystalline hybrid solid for the separation of mixtures of molecules having different degrees and/or a different number of unsaturations

Growing community of inventors

Trappes, France

Patricia Horcajada-Cortes